Management and prognosis of metastatic ovarian carcinoma from nongenital tract
- VernacularTitle:非生殖道来源的转移性卵巢癌的治疗及预后
- Author:
Xufeng WU
;
Yi CHEN
- Publication Type:Journal Article
- Keywords:
Ovarian neoplasms;
Surgical procedures, operative;
Drug therapy;
Prognosis
- From:
Chinese Journal of Obstetrics and Gynecology
2001;0(06):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the management and prognosis of nongenital metastatic ovarian carcinoma. Methods Thirty-four patients with nongenital metastatic ovarian carcinoma who were admitted in to Zhongnan Hospital of Wuhan University between 1998 and 2004 were analyzed retrospectively. Results The median survival time of group A (optimal cytoreductive surgery), group B (optimal cytoreductive surgery+chemotherapy), group C (sub-optimal cytoreductive surgery) and group D (sub-optimal cytoreductive surgery+chemotherapy ) was 5.0,10.0,4.0 and 6.5 months, respectively. The difference was significant between groups A and B, B and C, as well as between group C and D(P
